Target intelligence / Profile preview

NAA50 pseudogene 2 (NAA50P2)

Target: NAA50P2
Molecular classification: Other (pseudogene; not a functional enzyme, receptor, or typical molecular class)

Overview

NAA50 pseudogene 2 (NAA50P2) is a non-coding pseudogene related to the NAA50 gene, which encodes N-terminal acetyltransferase 50, an enzyme involved in protein N-terminal acetylation[1][2]. Pseudogenes like NAA50P2 generally arise from duplication or retrotransposition events and are often transcriptionally inactive, lacking protein-coding capacity or therapeutic relevance. The biologically and pharmacologically relevant entity is the NAA50 protein, not its pseudogenes. There is no evidence that NAA50P2 encodes a functional protein, is involved in disease, or interacts with any drugs.

Other names: NAA50P2NAA50 pseudogene 2

Beyond the preview

Go deeper on NAA50 pseudogene 2 (NAA50P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAA50 pseudogene 2 (NAA50P2).

Explore the full profile